YPrime Alternatives & Competitors
12 companies similar to YPrime — We pioneer solutions that streamline the clinical trial journey, increasing cert...
Companies similar to YPrime
Mosio for Research
Mosio helps researchers engage, retain, and collect data from study subjects more efficien...
Cenduit
Accelerating clinical trials through: Quality, Flexibility & Expertise.
Rival Readout
Competing with YPrime? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Medable
Leading the technology revolution in clinical development.
Castor
Real-world ready. Remote-first. AI-powered - Our technology is designed to ease the load a...
Clariness
Supporting clinical trials worldwide through patient recruitment, study feasibility, surve...
Datacubed Health
DCT Major Contender in Everest Group's Decentralized Clinical Trial Platforms PEAK Matrix®...
PharPoint Research, Inc.
We're a contract research organization (CRO) that helps innovative clients meet their clin...
InnovoCommerce
Leading Provider in AI-Augmented eClinical Solutions
About YPrime
YPrime is a pioneering company in the healthcare, information technology, and pharmaceutical industries, founded in 2006 and headquartered in the United States. The company's slogan, "We pioneer solutions that streamline the clinical trial journey, increasing certainty from study design to data lock," reflects its miss...
Clinical Trial, EConsent, IRT, ECOA, Patient Engagement, Technology Platform, Data Lock, Study Design, Certainty, Clinical Research
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around YPrime: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at YPrime on 12 Sep 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 16 Jul 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.